Creative Bioarray Releases Intergrated In Vitro Metabolism Services to Accelerate The Drug Discovery Process
New York, Oct 22nd, 2019 – Creative Bioarray announced the release of its in vitro metabolism services. As a world-leading biotechnology products and services provider, Creative Bioarray equipped this flagship program with high standard and cost-effective solutions, including drug metabolic stability services and drug-drug interaction services, to accelerate drug development process. The in vitro metabolism services integrate many of in vitro metabolism assays developed by Creative Biorray for offering reliable data of high consistency and quality, and evaluating the effects of the test drug on the metabolism of other drugs.
In the pharmaceutical process, it’s a very important step to understand the metabolic pathways of drugs in the early stages of drug development to better predict drug toxicity or side effects, drug-drug interactions, and obtaining information that will help in the formulation of drug delivery strategies. With a highly automated approach, Creative Bioarray offers cost-effective S9 stability assays to evaluate the metabolic stability of drug candidates. Experienced experts also provide microsomal stability assays based on specific requests. The S9 stability assay can be further extended to metabolite profiling and provide more information on compound metabolism. Liver microsome stability assays and hepatocyte stability assays are also available from Creative Bioarray.
Besides, Creative Bioarray is also committed to providing efficient and reliable microsomal stability testing services to accelerate the drug development process. The metabolism of the drug in the body and its formation of metabolites are also important parameters for assessing the bioavailability, toxicity and drug delivery potential of the compound, which makes it extremely necessary to detect the metabolic stability of candidate drugs early in the discovery process. Creative Bioarray provides microsomal stability assays for all small compounds such as pharmaceuticals, industrial chemicals and customer products to help researchers identify metabolic properties earlier and focus on improving drug candidates through structure-activity relationships.
Plasma stability plays an important role in drug discovery and development. Plasma instability can lead to poor in vivo performance, making pharmacokinetic studies full of unknown variables. The plasma stability assay provided by Creative Bioarray can be applied to measure the stability of compounds in plasma in a variety of species including humans, mice, and rats. Creative Bioarray typically utilizes HPLC-MS to determine the plasma stability of the test compound, providing high quality test services and data, as well as customized assay services for the study.
“Due to the complexity of the drug development process, a flexible partner will be ideal to provide reliable support for your specific needs.” said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, “With extensive experience and knowledge in drug development, we are capable to offer a variety of flexible and integrated services for drug discovery. Our experienced research team and state-of-the-art facilities enable us to provide our customers flexibility and customized assays with high competitive price and reliable reports.”
About Creative Bioarray
Founded in 2005, Creative Bioarray is dedicated to offering customers with innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house experts supported, Creative Bioarray has already countenanced research all around the world.
Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road Shirley
City: Long Island City
State: New York
Country: United States
Website: http://www.creative-bioarray.com
